651 filings
Page 18 of 33
8-K
axlg95a6gp1zb8e9s0
1 Oct 14
Departure of Directors or Certain Officers
12:00am
8-K
1stnesz
30 Sep 14
Other Events
12:00am
8-K
0ptcy hqdo3zq85
30 Sep 14
Biota Pharmaceuticals Reportsfourth Quarter
12:00am
NT 10-K
l4y xcb5qedslnjrdbd
15 Sep 14
Notice of late annual filing
12:00am
8-K
eh71tto
1 Aug 14
Biota Reportstop-linedata Fromitsphase 2 “Igloo” Trial
12:00am
8-K
zsgs9lcppgr3pz25eej7
2 Jun 14
Biota Announces Restructuring Plan
12:00am
8-K
ppyx44sbjm8kra8vn
8 May 14
Biota Provides Update on Barda Contract for Laninamivir Octanoate
12:00am
8-K
tzbqo8yjonhb1 sy0406
7 May 14
Biota Pharmaceuticals Reports Third Quarter 2014
12:00am
8-K
ybo92ps7cm90a14mbi4e
1 May 14
Biota Provides an Update on the Development of Laninamivir Octanoate
12:00am
8-K
8dwtotg4
30 Apr 14
Changes in Registrant's Certifying Accountant
12:00am
8-K
dk7mj1agdbt3ui0k65t
29 Apr 14
Results of Operations and Financial Condition
12:00am
8-K
bvs64iebqekclb59z4
10 Feb 14
Biota Pharmaceuticals Reports Second Quarter 2013
12:00am
8-K
v85w6ttw7f2 x6hzhg0a
14 Jan 14
Biota Announces Full Exercise of Over-allotment Option
12:00am
424B5
7fopps nt
10 Jan 14
Prospectus supplement for primary offering
12:00am
8-K
oyreo y7pwgu
10 Jan 14
Biota Prices $25 Million Public Offering
12:00am